Castle Biosciences Stock Forum

$Castle Biosciences(CSTL.US)$ New Publication Shows DecisionDx®-SCC Identifies High-Risk Squamous Cell Carcinoma Patients Who Are Likely to Benefit from Adjuvant Radiation Therapy and Those Who Can Consider Deferring Treatment Based on Biological Risk of Metastasis 1 MINUTE AGO, 4:30 PM EDT VIA BUSINESSWIRE

$Castle Biosciences(CSTL.US)$ Keeping a close eye to see what comes out of this? (. New Data Highlights Clinical Utility and Performance of Castle Biosciences' Dermatologic Test Portfolio at the 2023 Fall Clinical Dermatology Conference
Businesswire· 4 mins ago

$Castle Biosciences(CSTL.US)$ DecisionDx®-Melanoma Outperforms Memorial Sloan Kettering Cancer Center (MSKCC) Nomogram in Predicting Sentinel Lymph Node Positivity in Patients with Cutaneous Melanoma

$Castle Biosciences(CSTL.US)$ Castle Biosciences TissueCypher Barrett's Esophagus Test Outperformed Standard Of Care In Risk-Stratifying Patients With Barrett's Esophagus

Follow for daily best watchlist ⭐️🚀
$Applied Digital(APLD.US)$ $Alibaba(BABA.US)$ $Citigroup(C.US)$ $Caterpillar(CAT.US)$ $Caribou Biosciences(CRBU.US)$ $Castle Biosciences(CSTL.US)$ $Cintas(CTAS.US)$ $Greenidge Generation(GREE.US)$ $Gorilla Technology(GRRR.US)$ $3M(MMM.US)$ $PepsiCo(PEP.US)$ $Pfizer(PFE.US)$ $WD-40(WDFC.US)$ $TMC the metals(TMC.US)$ $Wynn Resorts(WYNN.US)$